Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy? [Yahoo! Finance]
Recursion Pharmaceuticals, Inc. - Class A (RXRX)
Company Research
Source: Yahoo! Finance
Picking the corporations driving these changes could pay off massive dividends -- literally and figuratively -- down the road. Though plenty of high-profile companies are looking to get in on the act, let's consider one relatively small and unknown player seeking to make a dent: Recursion Pharmaceuticals (NASDAQ: RXRX) . This mid-cap biotech has big ideas, but are the company's shares worth buying? Revolutionizing the drug development process Developing and marketing novel drugs is a painfully slow process. It is also risky; most therapies tested on humans never earn regulatory approval. Meanwhile, thousands of patients suffer and die while waiting for a medicine that could have eased their pain. Recursion wants to change that. The company uses an AI-powered operating system (OS) to test how millions of clinical compounds would interact with the human body and possibly treat various illnesses. The goal here isn't just to speed up the discovery process. The biotech wants to max
Show less
Read more
Impact Snapshot
Event Time:
RXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXRX alerts
High impacting Recursion Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RXRX
News
- Recursion (RXRX) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]Yahoo! Finance
- Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]Yahoo! Finance
- Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9GlobeNewswire
- Recursion to Participate in Upcoming Investor ConferencesGlobeNewswire
RXRX
Earnings
- 2/27/24 - Beat
RXRX
Sec Filings
- 5/3/24 - Form 4
- 5/2/24 - Form 4
- 5/2/24 - Form 144
- RXRX's page on the SEC website